A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 143

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 143
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 209
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 994
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3134
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 574
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 488
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Population pharmacokinetic and safety analysis of ropivacaine used for erector spinae plane blocks. | LitMetric

AI Article Synopsis

  • Erector spinae plane blocks are increasingly used for pain management in thoracic surgery, but there's a risk of systemic toxicity and intercostal spread with the anesthetic ropivacaine.
  • A study of 15 patients revealed the average concentration of ropivacaine reached potentially toxic levels in some cases, suggesting that dosing based on ideal body weight could reduce this risk.
  • The findings recommend adjusting the administration of ropivacaine to lower doses to minimize the likelihood of toxicity, particularly for patients who weigh less.

Article Abstract

Introduction: Erector spinae plane blocks have become popular for thoracic surgery. Despite a theoretically favorable safety profile, intercostal spread occurs and systemic toxicity is possible. Pharmacokinetic data are needed to guide safe dosing.

Methods: Fifteen patients undergoing thoracic surgery received continuous erector spinae plane blocks with ropivacaine 150 mg followed by subsequent boluses of 40 mg every 6 hours and infusion of 2 mg/hour. Arterial blood samples were obtained over 12 hours and analyzed using non-linear mixed effects modeling, which allowed for conducting simulations of clinically relevant dosing scenarios. The primary outcome was the C of ropivacaine in erector spinae plane blocks.

Results: The mean age was 66 years, mean weight was 77.5 kg, and mean ideal body weight was 60 kg. The mean C was 2.5 ±1.1 mg/L, which occurred at a median time of 10 (7-47) min after initial injection. Five patients developed potentially toxic ropivacaine levels but did not experience neurological symptoms. Another patient reported transient neurological toxicity symptoms. Our data suggested that using a maximum ropivacaine dose of 2.5 mg/kg based on ideal body weight would have prevented all toxicity events. Simulation predicted that reducing the initial dose to 75 mg with the same subsequent intermittent bolus dosing would decrease the risk of toxic levels to <1%.

Conclusion: Local anesthetic systemic toxicity can occur with erector spinae plane blocks and administration of large, fixed doses of ropivacaine should be avoided, especially in patients with low ideal body weights. Weight-based ropivacaine dosing could reduce toxicity risk.

Trial Registration Number: NCT04807504; clinicaltrials.gov.

Download full-text PDF

Source
http://dx.doi.org/10.1136/rapm-2022-104252DOI Listing

Publication Analysis

Top Keywords

erector spinae
16
spinae plane
16
plane blocks
12
ropivacaine erector
8
thoracic surgery
8
ideal body
8
body weight
8
ropivacaine
5
population pharmacokinetic
4
pharmacokinetic safety
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!